In 2017–2018, 16 out of 130 samples (12.3%) tested positive for recent CHIKV infections based on CHIKV RT-qPCR or anti-CHIKV IgM results, while in 2019–2020, 7 out of 188 samples (3.7%) showed recent infections. This evidence concerns the gene CD40LG and infection.